Bone Marrow-derived Mesenchymal Stem Cells Facilitate Engineering of Long-lasting Functional Vasculature

Overview

Journal Blood

Publisher Elsevier

Specialty Hematology

Date 2008 Feb 8

PMID 18256324

Citations 251

Authors

Patrick Au

Joshua Tam

Dai Fukumura

Rakesh K Jain

Affiliations

Soon will be listed here.

Abstract

Vascular tissue engineering requires a ready source of endothelial cells and perivascular cells. Here, we evaluated human bone marrow-derived mesenchymal stem cells (hMSCs) for use as vascular progenitor cells in tissue engineering and regenerative medicine. hMSCs expressed a panel of smooth muscle markers in vitro including the cardiac/smooth muscle-specific transcription coactivator, myocardin. Cell-cell contact between endothelial cells and hMSCs up-regulated the transcription of myocardin. hMSCs efficiently stabilized nascent blood vessels in vivo by functioning as perivascular precursor cells. The engineered blood vessels derived from human umbilical cord vein endothelial cells and hMSCs remained stable and functional for more than 130 days in vivo. On the other hand, we could not detect differentiation of hMSCs to endothelial cells in vitro, and hMSCs by themselves could not form conduit for blood flow in vivo. Similar to normal perivascular cells, hMSC-derived perivascular cells contracted in response to endothelin-1 in vivo. In conclusion, hMSCs are perivascular cell precursors and may serve as an attractive source of cells for use in vascular tissue engineering and for the study of perivascular cell differentiation.

Citing Articles

Leveraging the predictive power of a 3D in vitro vascularization screening assay for hydrogel-based tissue-engineered periosteum allograft healing.

March A, Hebner T, Choe R, Benoit D Biomater Adv. 2025; 169:214187.

PMID: 39827700 PMC: 11815559. DOI: 10.1016/j.bioadv.2025.214187.

Implantable 3D printed hydrogels with intrinsic channels for liver tissue engineering.

Lieberthal T, Sahakyants T, Szabo-Wexler N, Hancock M, Spann A, Oliver M Proc Natl Acad Sci U S A. 2024; 121(47):e2403322121.

PMID: 39531491 PMC: 11588097. DOI: 10.1073/pnas.2403322121.

Bone Spheroid Development Under Flow Conditions with Mesenchymal Stem Cells and Human Umbilical Vein Endothelial Cells in a 3D Porous Hydrogel Supplemented with Hydroxyapatite.

El Hajj S, Ntate M, Breton C, Siadous R, Aid R, Dupuy M Gels. 2024; 10(10).

PMID: 39451319 PMC: 11506954. DOI: 10.3390/gels10100666.

A hybrid construct with tailored 3D structure for directing pre-vascularization in engineered tissues.

Neves S, Sousa A, Nascimento D, Orge I, Ferreira S, Mota C Mater Today Bio. 2024; 29:101291.

PMID: 39435373 PMC: 11492604. DOI: 10.1016/j.mtbio.2024.101291.

Robust differentiation of human pluripotent stem cells into mural progenitor cells via transient activation of NKX3.1.

Lee U, Zhang Y, Zhu Y, Luo A, Gong L, Tremmel D Nat Commun. 2024; 15(1):8392.

PMID: 39349465 PMC: 11442894. DOI: 10.1038/s41467-024-52678-8.

References

Brown E, Campbell R, Tsuzuki Y, Xu L, Carmeliet P, Fukumura D . In vivo measurement of gene expression, angiogenesis and physiological function in tumors using multiphoton laser scanning microscopy. Nat Med. 2001; 7(7):864-8. DOI: 10.1038/89997. View

Schechner J, Nath A, Zheng L, Kluger M, Hughes C, Lorber M . In vivo formation of complex microvessels lined by human endothelial cells in an immunodeficient mouse. Proc Natl Acad Sci U S A. 2000; 97(16):9191-6. PMC: 16844. DOI: 10.1073/pnas.150242297. View

Kattman S, Huber T, Keller G . Multipotent flk-1+ cardiovascular progenitor cells give rise to the cardiomyocyte, endothelial, and vascular smooth muscle lineages. Dev Cell. 2006; 11(5):723-32. DOI: 10.1016/j.devcel.2006.10.002. View

Nagaya N, Fujii T, Iwase T, Ohgushi H, Itoh T, Uematsu M . Intravenous administration of mesenchymal stem cells improves cardiac function in rats with acute myocardial infarction through angiogenesis and myogenesis. Am J Physiol Heart Circ Physiol. 2004; 287(6):H2670-6. DOI: 10.1152/ajpheart.01071.2003. View

Au P, Daheron L, Duda D, Cohen K, Tyrrell J, Lanning R . Differential in vivo potential of endothelial progenitor cells from human umbilical cord blood and adult peripheral blood to form functional long-lasting vessels. Blood. 2007; 111(3):1302-5. PMC: 2214740. DOI: 10.1182/blood-2007-06-094318. View

Lindahl P, Johansson B, Leveen P, Betsholtz C . Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. Science. 1997; 277(5323):242-5. DOI: 10.1126/science.277.5323.242. View

Yoshida T, Sinha S, Dandre F, Wamhoff B, Hoofnagle M, Kremer B . Myocardin is a key regulator of CArG-dependent transcription of multiple smooth muscle marker genes. Circ Res. 2003; 92(8):856-64. DOI: 10.1161/01.RES.0000068405.49081.09. View

Wang Z, Au P, Chen T, Shao Y, Daheron L, Bai H . Endothelial cells derived from human embryonic stem cells form durable blood vessels in vivo. Nat Biotechnol. 2007; 25(3):317-8. DOI: 10.1038/nbt1287. View

Yamashita J, Itoh H, Hirashima M, Ogawa M, Yurugi T, Naito M . Flk1-positive cells derived from embryonic stem cells serve as vascular progenitors. Nature. 2000; 408(6808):92-6. DOI: 10.1038/35040568. View

10.

Hirschi K, Rohovsky S, DAmore P . PDGF, TGF-beta, and heterotypic cell-cell interactions mediate endothelial cell-induced recruitment of 10T1/2 cells and their differentiation to a smooth muscle fate. J Cell Biol. 1998; 141(3):805-14. PMC: 2132737. DOI: 10.1083/jcb.141.3.805. View

11.

Fuchs S, Battler A, Kornowski R . Catheter-based stem cell and gene therapy for refractory myocardial ischemia. Nat Clin Pract Cardiovasc Med. 2007; 4 Suppl 1:S89-95. DOI: 10.1038/ncpcardio0762. View

12.

Jain R . Molecular regulation of vessel maturation. Nat Med. 2003; 9(6):685-93. DOI: 10.1038/nm0603-685. View

13.

Giordano A, Galderisi U, Marino I . From the laboratory bench to the patient's bedside: an update on clinical trials with mesenchymal stem cells. J Cell Physiol. 2007; 211(1):27-35. DOI: 10.1002/jcp.20959. View

14.

Oswald J, Boxberger S, Jorgensen B, Feldmann S, Ehninger G, Bornhauser M . Mesenchymal stem cells can be differentiated into endothelial cells in vitro. Stem Cells. 2004; 22(3):377-84. DOI: 10.1634/stemcells.22-3-377. View

15.

Kaigler D, Krebsbach P, West E, Horger K, Huang Y, Mooney D . Endothelial cell modulation of bone marrow stromal cell osteogenic potential. FASEB J. 2005; 19(6):665-7. DOI: 10.1096/fj.04-2529fje. View

16.

Ross J, Hong Z, Willenbring B, Zeng L, Isenberg B, Lee E . Cytokine-induced differentiation of multipotent adult progenitor cells into functional smooth muscle cells. J Clin Invest. 2006; 116(12):3139-49. PMC: 1635164. DOI: 10.1172/JCI28184. View

17.

Wang D, Chang P, Wang Z, Sutherland L, Richardson J, Small E . Activation of cardiac gene expression by myocardin, a transcriptional cofactor for serum response factor. Cell. 2001; 105(7):851-62. DOI: 10.1016/s0092-8674(01)00404-4. View

18.

Prockop D . Marrow stromal cells as stem cells for nonhematopoietic tissues. Science. 1997; 276(5309):71-4. DOI: 10.1126/science.276.5309.71. View

19.

Sinha S, Hoofnagle M, Kingston P, McCanna M, Owens G . Transforming growth factor-beta1 signaling contributes to development of smooth muscle cells from embryonic stem cells. Am J Physiol Cell Physiol. 2004; 287(6):C1560-8. DOI: 10.1152/ajpcell.00221.2004. View

20.

Peppiatt C, Howarth C, Mobbs P, Attwell D . Bidirectional control of CNS capillary diameter by pericytes. Nature. 2006; 443(7112):700-4. PMC: 1761848. DOI: 10.1038/nature05193. View